VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 50 filers reported holding VOR BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,698,310 | -31.4% | 6,461,467 | 0.0% | 0.93% | -39.7% |
| Q2 2023 | $19,965,933 | -42.7% | 6,461,467 | -0.3% | 1.54% | -53.3% |
| Q1 2023 | $34,851,635 | -18.7% | 6,477,999 | +0.5% | 3.30% | -34.3% |
| Q4 2022 | $42,844,786 | +531.8% | 6,442,825 | +278.2% | 5.03% | +456.3% |
| Q3 2022 | $6,781,000 | +4.6% | 1,703,645 | +30.6% | 0.90% | -30.0% |
| Q2 2022 | $6,482,000 | +20.0% | 1,304,300 | +45.8% | 1.29% | -9.5% |
| Q1 2022 | $5,402,000 | -26.1% | 894,404 | +42.1% | 1.43% | -31.6% |
| Q4 2021 | $7,313,000 | – | 629,342 | – | 2.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $34,226,070 | 8.75% |
| OUP Management Co., LLC | 374,714 | $2,015,961 | 4.02% |
| Paradigm Biocapital Advisors LP | 6,477,999 | $34,851,635 | 3.30% |
| RA Capital Management | 22,748,880 | $122,388,974 | 2.77% |
| JOHNSON & JOHNSON | 1,074,658 | $5,781,660 | 1.88% |
| Artal Group S.A. | 2,792,805 | $15,025 | 0.89% |
| Trustees of Columbia University in the City of New York | 91,910 | $494,476 | 0.88% |
| Sarissa Capital Management LP | 618,000 | $3,324,840 | 0.42% |
| Laurion Capital Management LP | 3,182,889 | $17,123,943 | 0.12% |
| Woodline Partners LP | 1,111,123 | $5,977,842 | 0.08% |